Literature DB >> 1387885

Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.

L C Miller1, S Isa, E Vannier, K Georgilis, A C Steere, C A Dinarello.   

Abstract

Lyme arthritis is one of the few forms of chronic arthritis in which the cause is known with certainty. Because cytokines are thought to contribute to the pathogenesis of chronic arthritis, we investigated the effect of the Lyme disease spirochete, Borrelia burgdorferi, on the gene expression and synthesis of IL-1 beta and the IL-1 receptor antagonist (IL-1ra) in human peripheral blood mononuclear cells. Live B. burgdorferi induced fivefold more IL-1 beta than IL-1 alpha and sevenfold more IL-1 beta than IL-1ra; LPS or sonicated B. burgdorferi induced similar amounts of all three cytokines. This preferential induction of IL-1 beta was most dramatic in response to a low passage, virulent preparation of B. burgdorferi vs. three high passage avirulent strains. No difference in induction of IL-1ra was seen between these strains. The marked induction of IL-1 beta was partially diminished by heat-treatment and abrogated by sonication; IL-1ra was not affected. This suggested that a membrane component(s) accounted for the preferential induction of IL-1 beta. However, recombinant outer surface protein beta induced little IL-1 beta. By 4 h after stimulation, B. burgdorferi induced sixfold more IL-1 beta protein than LPS. In contrast to LPS-induced IL-1 beta mRNA which reached maximal accumulation after 3 h, B. burgdorferi-induced IL-1 beta mRNA showed biphasic elevations at 3 and 18 h. B. burgdorferi-induced IL-1ra mRNA peaked at 12 h, whereas LPS-induced IL-1ra mRNA peaked at 9 h. IL-1 beta synthesis increased in response to increasing numbers of spirochetes, whereas IL-1ra synthesis did not. The preferential induction by B. burgdorferi of IL-1 beta over IL-1ra is an example of excess agonist over antagonist synthesis induced by a microbial pathogen, and may contribute to the destructive lesion of Lyme arthritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1387885      PMCID: PMC329945          DOI: 10.1172/JCI115966

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Monoclonal antibodies to the soluble human IL-6 receptor: affinity purification, ELISA, and inhibition of ligand binding.

Authors:  D Novick; H Engelmann; M Revel; O Leitner; M Rubinstein
Journal:  Hybridoma       Date:  1991-02

2.  Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles.

Authors:  A C Steere; E Dwyer; R Winchester
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

3.  Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist.

Authors:  S P Eisenberg; R J Evans; W P Arend; E Verderber; M T Brewer; C H Hannum; R C Thompson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

Review 4.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

5.  In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation.

Authors:  S Endres; J G Cannon; R Ghorbani; R A Dempsey; S D Sisson; G Lonnemann; J W Van der Meer; S M Wolff; C A Dinarello
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

6.  Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells.

Authors:  K Georgilis; A C Steere; M S Klempner
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

Review 7.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

8.  IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently.

Authors:  W P Arend; M F Smith; R W Janson; F G Joslin
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

Review 9.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro.

Authors:  C A Dinarello; R C Thompson
Journal:  Immunol Today       Date:  1991-11

10.  Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated.

Authors:  D D Poutsiaka; B D Clark; E Vannier; C A Dinarello
Journal:  Blood       Date:  1991-09-01       Impact factor: 22.113

View more
  26 in total

1.  The importance of interleukin 1beta in Helicobacter pylori associated disease.

Authors:  E M El-Omar
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

Review 2.  Host-pathogen interactions in the immunopathogenesis of Lyme disease.

Authors:  L T Hu; M S Klempner
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

3.  2nd European Symposium on Lyme Borreliosis. A NATO advanced research workshop. United Kingdom, 19-20 May 1993. Abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

4.  Fetal outcome in murine Lyme disease.

Authors:  R M Silver; L Yang; R A Daynes; D W Branch; C M Salafia; J J Weis
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

5.  Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes.

Authors:  E Caron; T Peyrard; S Köhler; S Cabane; J P Liautard; J Dornand
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

6.  Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA.

Authors:  K F Tai; Y Ma; J J Weis
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1.

Authors:  Malte Bachmann; Katharina Horn; Ina Rudloff; Itamar Goren; Martin Holdener; Urs Christen; Nicole Darsow; Klaus-Peter Hunfeld; Ulrike Koehl; Peter Kind; Josef Pfeilschifter; Peter Kraiczy; Heiko Mühl
Journal:  PLoS Pathog       Date:  2010-10-14       Impact factor: 6.823

8.  Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.

Authors:  K P Seiler; Z Vavrin; E Eichwald; J B Hibbs; J J Weis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

9.  Specific adherence of Borrelia burgdorferi extracellular vesicles to human endothelial cells in culture.

Authors:  R J Shoberg; D D Thomas
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.

Authors:  Y Ma; J J Weis
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.